Joint Action on Strengthened International Health Regulations and Preparedness in the EU (SHARP JA)
The Joint Action will strengthen implementation of IHR and preparedness against biological and chemical health threats in Europe.
Objectives
Improved capacity of participating countries to respond to cross-border biological and chemical threats, an thus improved health security in the EU.
Implementation
The Action includes 10 work packages: coordination, dissemination, evaluation, integration in national policies and sustainability, strengthening of IHR core capacities, preparedness and response planning, laboratory preparedness, training, chemical threats, as well as case management and infection prevention and control.
Partners
The partner organisations are from: Austria, Bosnia and Herzegovina, Chech Republic, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Serbia, Slovenia, Spain, Sweden, United Kingdom (26 countries), in addition collaborating partners from Belgium, Bulgaria, Iceland and Switzerland with own funding.
SHARP JA aims to support the work of WHO and ECDC, which are the most important cooperating partners.
Externally available deliverables
- D2.1 Leaflet – a four page overview of the SHARP Joint Action (PDF 324 KB)
- D2.4 A blueprint for effective programme communications for future EU Health Policy joint actions (PDF 1,991 KB)
- D2.5 Final communication and dissemination report activities and results, 1 October 2020 to August 2023 (PDF 2,170 KB)
- D3.1 Evaluation Plan (PDF 1,210 KB)
- D3.4 Midterm external evaluation report (PDF 638 KB)
- D3.5 Final external evaluation report (PDF 1,458 KB)
- D4.2 Sustainability Report (PDF 906 KB)
- D5.2 IHR Core Capacity Strengthening and Assessment (PDF 1,432 KB)
- D5.4 Review of EU-level Simulation Exercises and After Action Reviews (PDF 1,359 KB)
- D5.3 International collaboration between authorities during crisis (PDF 1,469 KB)
- D6.1 Multisectoral collaboration during public health emergencies: an integrative review (PDF 1,024 KB)
- D7.3 Recommendations for risk management - a Guidance Tool for Enhancing Biorisk Management in European Laboratories (EBRMGuidance Tool) (PDF 1,090 KB)
- D8.1 Report on training needs (PDF 2,427 KB)
- D8.2 Final Training Report (PDF 3,516 KB)
- D8.3 Basic and advanced training curricula (PDF 739 KB)
- D9.1 Chemical safety and chemical threats: Fact-finding report (PDF 1,275 KB)
- D9.2 Chemical laboratory response network – scoping report (PDF 693 KB)
- D9.3 WP9 Final Report (325 KB)
- D9.4 Report on Standard Operating Procedures (SOPs) for responding to chemical threats (937 KB)
- D10.1 Mapping of existing facilities for high-consequence infectious diseases and assessment of high level isolation units (PDF 2,217 KB)
- D10.2 Feasibility study for an expert clinical support service for high consequence infectious diseases (PDF 503 KB)
- D10.3 Application of a “syndrome based” approach for prompt and early clinical management of High Consequence Infectious Disease (PDF 1,275 KB)
Funding
For more information
sharp(at)thl.fi
Anna Katz
Project Manager
[email protected]
Outi Karvonen
Development Manager
[email protected]
